Svas Biosana S.p.A. (BIT:SVS)
Italy · Delayed Price · Currency is EUR 8.38
0.00 (0.00%)
At close: Aug 14, 2026
Svas Biosana Financials Overview
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 141.56 | 141.56 | 122.29 | 121.63 | 99.51 | 81.99 |
Revenue Growth | 4.89% | 15.76% | 0.54% | 22.23% | 21.37% | 6.11% |
Gross Profit Gross Profit Growth | 40.08 | 40.08 | 34.37 | 32.26 | 28.73 | 23.47 |
Operating Income Operating Income Growth | 12.24 | 12.24 | 9.8 | 8.57 | 6.28 | 5.77 |
Net Income Net Income Growth | 6.77 | 6.77 | 5.87 | 5.12 | 3.57 | 3.16 |
Earnings Per Share EPS Growth | 1.29 | 1.29 | 1.10 | - | 0.66 | - |
EPS Growth | - | 17.28% | - | - | - | - |
| Fiscal Year | TTM | FY 2025 |
|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 |
Italy Italy Growth | 67.25 | 67.25 |
European Union European Union Growth | 47.79 | 47.79 |
Non-EU Non-EU Growth | 24.07 | 24.07 |
Total Total Growth | 139.11 | 139.11 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 37.47 | 37.47 | 37.39 | 40 | 29.53 | 31.06 |
Total Debt Total Debt Growth | 76.41 | 76.41 | 65.97 | 67.18 | 55.26 | 54.34 |
Net Cash (Debt) Net Cash Growth | -38.93 | -38.93 | -28.58 | -27.18 | -25.74 | -23.28 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -7.44 | -7.44 | -5.36 | - | -4.75 | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 6.42 | 6.42 | 5.14 | 4.29 | 4.88 | 2.53 |
Capital Expenditures CapEx Growth | -3.69 | -3.69 | -3.72 | -3.77 | -2.99 | -2.62 |
Free Cash Flow Free Cash Flow Growth | 2.73 | 2.73 | 1.42 | 0.52 | 1.9 | -0.08 |
Free Cash Flow Growth | - | 91.56% | 174.03% | -72.62% | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 28.32% | 28.32% | 28.10% | 26.52% | 28.87% | 28.62% |
Operating Margin | 8.64% | 8.64% | 8.02% | 7.04% | 6.31% | 7.04% |
Pretax Margin | 6.45% | 6.45% | 6.55% | 5.59% | 4.68% | 4.90% |
Profit Margin | 4.78% | 4.78% | 4.80% | 4.21% | 3.59% | 3.85% |
FCF Margin | 1.93% | 1.93% | 1.17% | 0.43% | 1.91% | -0.10% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Period Ending | Aug '26 Aug 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Dividend Per Share Dividend Per Share Growth | 0.200 | 0.200 | 0.250 | 0.300 |
Dividend Per Share Growth | -20.00% | -20.00% | -16.67% | - |
Dividend Yield | 2.39% | 2.56% | 3.71% | 4.11% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 6.48 | 6.28 | 6.52 | 8.43 | 15.29 | 27.47 |
Forward PE | 6.60 | 5.59 | 5.92 | 8.56 | 10.60 | - |
P/FCF Ratio | 16.04 | 15.58 | 26.90 | 83.07 | 28.74 | - |
PS Ratio | 0.31 | 0.30 | 0.31 | 0.36 | 0.55 | 1.06 |